K Yamazaki

A phase II trial of gefitinib as first-line therapy for advanced non-small cell lung cancer with epidermal growth factor receptor mutations

Hajime Asahina, K Yamazaki, Ichiro Kinoshita et al. · British Journal of Cancer · 2006 · 278 citations · Full text

Medicine, Oncology, Pharmacology +14

Virtual bronchoscopic navigation combined with endobronchial ultrasound to diagnose small peripheral pulmonary lesions: a randomised trial

Takashi Ishida, Fumihiro Asano, K Yamazaki et al. · Thorax · 2011 · 262 citations · Full text

Medicine, Clinical Sciences, Radiology +14

N-acetylgalactosaminyl transferase-3 is a potential new marker for non-small cell lung cancers

Hirotoshi Dosaka‐Akita, Ichiro Kinoshita, K Yamazaki et al. · British Journal of Cancer · 2002 · 43 citations · Full text

Medicine, Molecular Biology, Oncology +16

Growth inhibition of non-small cell lung cancer cells by AP-1 blockade using a cJun dominant-negative mutant

Yasushi Shimizu, Ichiro Kinoshita, Junko Kikuchi et al. · British Journal of Cancer · 2008 · 33 citations · Full text

Life Sciences, Cell Biology, Oncology +16

Small cell lung carcinomas express shared and private tumor antigens presented by HLA-A1 or HLA-A2.

K Yamazaki, Gina Spruill, J B Rhoderick et al. · PubMed · 1999 · 27 citations

Life Sciences, Immunology, Oncology +17